
Thailand Selects 44 Medical AI Startups for Commercial Push
More than 80 firms applied to join the state-backed initiative aimed at moving clinical prototypes into hospitals and global markets.
Tag
79 stories in this topic

More than 80 firms applied to join the state-backed initiative aimed at moving clinical prototypes into hospitals and global markets.

The PRUActive Family Care policy includes critical illness add-ons covering 182 conditions without requiring medical underwriting for parents.

The new facility triples testing space in Kentucky and targets a 50 per cent cut in batch release turnaround times for sterile injectables.

Capped clinic fees take effect across nearly 1,000 private medical practices and all polyclinics as the Ministry of Health responds to rising respiratory admissions.

The Danish drugmaker presented the formulation to more than 500 medical practitioners to address cardiovascular-kidney-metabolic syndrome.

Waste accounts for a quarter of regional medical spending while out-of-pocket costs climbed up to 13 per cent in Singapore and Australia.

Malaysia launched a pilot program on 1 September to reference Singapore assessments, aiming to eliminate duplicated reviews and accelerate pharmaceutical market entry across Southeast Asia.

Dr Neal Kassell of the Focused Ultrasound Foundation says global trials for pancreatic and brain cancers could yield major results within three years.

Communications Minister Datuk Seri Fahmi Fadzil confirmed the measure following talks with medical associations and healthcare experts in Kuala Lumpur.

The 400-bed facility in Sunway City Iskandar Puteri anchors a broader pipeline aimed at reaching eight hospitals across Malaysia by 2032.

A new five-year plan requires large pharma firms to generate 3.5 trillion yuan in revenue and produce 50 drugmakers earning over 10 billion yuan each.

The Hong Kong herbal pain relief manufacturer rolled out a 27 per cent sitewide discount and high-tier spend incentives on its direct webstore.

The Goyang recovery center will be the luxury fashion brand’s first dedicated cancer care facility in Asia.

Backed by Hong Leong and TPG, the regional hospital operator plans to file IPO documents in November ahead of a listing targeted for early 2027.

The US telehealth group is replacing Eucalyptus’s men’s health brand Pilot as it targets 1 billion dollars in international annual revenue within three years.

With direct drug ads banned in China, pharmaceutical giants are chasing a market projected to reach 30 billion yuan through public lifestyle campaigns.
Weekly Briefing
Monday, Wednesday and a Friday Weekly Wrap: the retail stories, numbers and moves that mattered across Asia. Nothing else, and you can unsubscribe in one click.
Read by retail operators, investors and brand teams across Asia.